Gene_IDGene NameGene Symbol Fold change compared to control hCG28493.2retinol dehydrogenase 8 (all-trans) RDH82.09 hCG178118 1.1 ankyrin repeat domain.

Slides:



Advertisements
Similar presentations
Cancer and Cell Biology. Cancer Facts Group of 100 diseases that develop across time Characterized by uncontrolled cell division Can develop in virtually.
Advertisements

Virtual Workshop for Alliance for Cancer Prevention Endocrine Disrupters and Human Health Professor Susan Jobling Institute for the Environment Brunel.
Biomarkism: taming the revolution? May 12 th 2014 PSI Conference David Lovell St George’s Medical School University of London.
Evaluating Existing in vitro Endocrine Data Jeff Pregenzer, Director of Endocrine Studies, CeeTox.
Toxicological report Bio 464
The international journal for all the latest news and research Online Power Point Presentation.
The Challenge of Prostate Cancer Genitourinary Cancer Center at M. D. Anderson PERSONALIZED MEDICINE.
Nonylphenol in Water By Jackie Fawcett & Michael Goldrich.
Early programming hypothesis Wilfried Karmaus Reproductive Epidemiology EPI 824.
BRCA2 Blue: Rad51; Green: BRCA2
PCR Application: Can Breast Cancer be Cured?. Normal, Healthy Cells Cells can change or differentiate to become specialised according to the tissue that.
Geonomics in Breast Cancer Decoding Human Genome Luis Barreras, M.D., FACP.
Breast Cancer By: Will Wellman. About Breast Cancer  Breast cancer is a form of cancer that happens in the cells of the breast.  Breast cancer is most.
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
Malignant Melanoma and CDKN2A
METHODS This project is an evidence based literature review conducted using the databases of Medline, AbstractsFirst, and Cochrane. The search terms used.
Breast cancer screening Mammography is the most widely used screening modality, with solid evidence of benefit for women aged 40 to 74 years Clinical breast.
Vitamin D and breast cancer risk: epidemiological evidence Tom Rohan Dept. of Epidemiology and Population Health Albert Einstein College Of Medicine.
Breast Cancer Genetic Risk Communicating with Your Family Mary B. Daly, M.D., Ph.D. April 3, 2012.
Menopause: The Journal of The North American Menopause Society
1 Causation in Epidemiological Studies Dr. Birgit Greiner Senior Lecturer.
3) Campbell, Colin T., Campbell, Thomas M. The China Study. Dallas, Texas: BenBella Books Inc., ) “National Diabetes Surveillance System”. Center.
Objective  To determine the influence of hormone therapy in periodontal disease through the intake assessment of antiestrogen tamoxifen in women with.
Selected Bibliography Discussion -Adami, H., Lipworth, L., Titus-Ernstoff, L., Hsieh, C., Hanberg, A., Ahlborg, U., Baron, J., and Trichopoulos, D. (1995).
High-density lipoprotein and very-low-density lipoprotein have opposing roles in regulating tumor-initiating cells and sensitivity to radiation in inflammatory.
Introduction The effects of HER2 gene and receptor over- expression on breast cancer. Prognosis and treatment of HER2+ breast cancer. (See figure 1)
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
Methodology Control (no treatment) Estrogen (5 uM) 4-nonylphenol (5 uM) Cultured Cells, Isolated RNA, RTed to cDNA Data analyzed by Spotfire software RT-PCR.
Evaluating the Effects of Environmental Toxin 4-Nonylphenol and Estrogen on U937 Human Immune Cells Via Microarray Analysis Esop Baek and Celline Kim Manhasset.
Endocrine disrupters. Endocrine disruption Endocrine disrupters (ED) or endocrine disrupting chemicals (EDC) are exogenous chemical agents that interfere.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Functional interactions between calmodulin and estrogen receptor-α
Determining the Effect of Triclosan on the Growth of Cancer Cells Lydia Alf and Winnifred Bryant Ph. D. Department of Biology University of Wisconsin,
Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets Node Patient 1Patient 2Patient 3 Primary Mets.
Pig snouts…Tasty goodness. Did you get a booger too? Celline Kim Final Presentation
Cancer Susceptibilit y Genes Environment polycyclic aromatic Hydrocarbons PAH P450, glutathione S- transferase (GST) N- acetyltransferase (NAT) P. Perera.
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Introduction Hereditary predisposition (mutations in BRCA1 and BRCA2 genes) contribute to familial breast cancers. Eighty percent of the.
Groups of 100 diseases that develop across time. Characterized by uncontrolled cell division. Can develop in virtually any of the body’s tissues. Hereditary.
Methodology U937 Human Immune Cells Control (No treatment) (n=4) Estrogen (5 uM) (n=4) 4-nonylphenol (5 uM) (n=4) Cultured Cells, RNA Isolation, RT (to.
Selected Bibliography Discussion -Adami, H., Lipworth, L., Titus-Ernstoff, L., Hsieh, C., Hanberg, A., Ahlborg, U., Baron, J., and Trichopoulos, D. (1995).
Breast cancer Not a single disease. Type and stage. Grade/Lympho-vascular invasion Molecular biology. ER\PR Her-2-neu Other. Gene expression profiling.
Jerrold J. Heindel PhD National Institute of Environmental Health Sciences National Institutes of Health/DHHS
Program on Reproductive Health and the Environment Moving into the Future: New Science and Decision Making Tracey J Woodruff, PhD, MPH Associate Professor,
No, they won’t infect you…… Celline Kim Final Presentation
Cancer and Cell Biology
Pathways involved in hereditary breast cancer
Genetic Risk Assessment and Genetic Counseling Research
A one-year audit of topics and domains in the Journal of the American Medical Association and the New England Journal of Medicine1  Steven H Woolf, MD,
Estrogen & Estrogen Receptor
Cell Biology and Cancer
Genetics In Breast Cancer
A Low Carbohydrate Nutritional Program Improves Weight, Insulin, and Estrogenic Parameters in Obese Patients with Estrogen Receptor Positive Endometrial.
G0S2 Represses PI3K/AKT/mTOR Signaling and Increases Sensitivity to PI3K/mTOR Pathway Inhibitors in Estrogen Receptor-Positive Breast Cancer Cells Christina.
Figure 1. (A) Cumulative risk of breast (diamonds) and ovarian (squares) cancer in BRCA1 mutation carriers. (B) Cumulative risk of breast (diamonds) and.
Cell Biology and Cancer Unit H.
ד"ר אלה עברון אונקולוגיה ומכון השד אסף הרופא
Fibroblast Growth Factor 3 (FGF3) int-2
breast cancer 2, early onset What does this protein make up or do?
Mammary Ductal Environment Is Necessary for Faithful Maintenance of Estrogen Signaling in ER+ Breast Cancer  Svasti Haricharan, Jonathan Lei, Matthew.
The decision tree with the two alternatives.
Specific Tumor Suppressor Genes
Abebe Genetu Bayih, PhD University of Gondar
COX-2, Oct-4, and ALDH-1 expression in the mammary gland.
Γ-TmT reduces serum E2 levels and induces estrogen-metabolizing enzyme CYP1A1 in E2-treated ACI rats. γ-TmT reduces serum E2 levels and induces estrogen-metabolizing.
Whole mounts (A-D; ×20), and H&E sections (E-H, ×100) of the mammary gland. Whole mounts (A-D; ×20), and H&E sections (E-H, ×100) of the mammary gland.
Ki-67 and ERα immunostaining in the mammary gland.
Presentation transcript:

Gene_IDGene NameGene Symbol Fold change compared to control hCG retinol dehydrogenase 8 (all-trans) RDH82.09 hCG ankyrin repeat domain 12 ANKRD hCG UDP glycosyltransferase 2 family, polypeptide B4 UGT2B hCG estrogen receptor 2 (ER beta) ESR hCG FLJ46358 proteinFLJ Evaluating the 5 potential biomarkers with other substances Testing the long-term effects of Estrogen and 4-Nonylphenol Future Studies Figure 4: Gene profiles of BRCA1 and BRCA2. The E2 treament induced a fold repression of more than two fold while the NP treatment had no significant effect. This phenomenon was observed for 23/45 genes in the portfolio involved in the onset of breast cancer. Relative Gene Expression (Signal of treatment chip/signal of chip treatment) Relative Gene Expression (Signal of treatment chip/signal of chip treatment) Gene Expressions Profiles of BRCA1 and BRCA2 -Adami, H., Lipworth, L., Titus-Ernstoff, L., Hsieh, C., Hanberg, A., Ahlborg, U., Baron, J., and Trichopoulos, D. (1995). Organochlorine compounds and estrogen-related cancers in women. Cancer Causes and Control. 6, Ahlborg, U. G., Lipworth, L., Titus-Ernstoff, L., Hsieh, C., Hanberg, A., Baron, J., Trichopoulos, D., and Adami, H. (1995). Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Critical Reviews in Toxicology. 25, Anderson, E., Clarke, R. B., and Howell, A. (1998). Estrogen responsiveness and control of normal human breast proliferation. Journal of Mammary Gland Biology and Neoplasia. 3, 23 -Ashby, J., Houthoff, E., Kennedy, S. J., Stevens, J., Bars, R., Jekat, F. W., Campbell, P., Miller, J. V., Carpanini, F. M., and Randall, G. L. P. (1997). The challenge posed by endocrine-disrupting chemicals. Environmental Health Perspectives Bennie, D. T Review of the environmental occurence of alkylphenols and alkylphenol ethoxylates. Water Quality Research Journal of Canada. 34(1): Brix, Rikke, Hvidt, Søren and Carlsen, Lars. (2003). Solubility of nonylphenol and nonyphenol-ethoxylates: On the possible role of micelles. Chemosphere. 44(4): pp Brown, N. M., and Lamartiniere, C. A. (1995). Xenoestrogens alter mammary gland differentiation and cell proliferation in the rat. Environmental Health Perspectives. 103, Cavalieri E, Chakravarti D, Guttenplan J, et al (2006). "Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention". Biochem. Biophys. Acta. 1766(1): 63–78. -Colborn T. (1993) Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environmental Health Perspectives. Oct;101(5): Davidson, N. E. (1998). Environmental estrogens and breast cancer risk. Current Opinion in Oncology 10, Davis, D. L., Bradlow, H. L., Wolff, M., Woodruff, T., Hoel, D. G., and Anton-Culver, H. (1993). Medical hypothesis: Xenoestrogens as preventable causes of breast cancer. Environmental Health Perspectives. 101, Ford, James, M.D., Plevritis, Sylvia, PhD. (2002) Genetic Alterations in MRI Screen-Detected Breast Lesions. Breast Cancer Research and Treatment. 7651; pp.618 Works Cited Discussion -4-Nonylphenol Altered the Effects of Almost 10 percent of the portfolio genes -5 to significant enough amounts to treat as possible biomarkers -Affected Several Genes in Estrogen-Pathway to the Same Extent